2002•LeukemiaRequires access

How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administration

Giovanna Meloni, SM Trisolini, Saveria Capria, GF Torelli, Erminia Baldacci, Concetta Torromeo, Guido Valesini, Franco Mandelli

Open publisher page 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Interleukin 2, Bone marrow, Internal medicine, IL-2 receptor, Leukemia, Aldesleukin, Gastroenterology

Back to paper search Browse research topics Original source

How long can we give interleukin-2? Clinical and immunological evaluation of AML patients after 10 or more years of IL2 administration — Research Paper | ScholarLens